Neoadjuvant Treatment with Preoperative Radiotherapy for Extremity Soft Tissue Sarcomas: Long-Term Results from a Single Institution in Turkey

Dincbas, Fazilet Oner; Oksuz, Didem Colpan; Yetmen, Ozlem; Hiz, Murat; Dervisoglu, Sergulen; Turna, Hande; Kantarci, Fatih; Mandel, Nil Molinas; Koca, Sedat

추천

검색

자료유형: 학술저널

저자정보: Dincbas, Fazilet Oner (Department of Radiation Oncology, Cerrahpasa Medical Faculty, Istanbul University) Oksuz, Didem Colpan (Department of Radiation Oncology, Cerrahpasa Medical Faculty, Istanbul University) Yetmen, Ozlem (Department of Radiation Oncology, Lutfi Kirdar Kartal Training and Research Hospital) Hiz, Murat (Department of Orthopedic Surgery, Cerrahpasa Medical Faculty, Istanbul University) Dervisoglu, Sergulen (Department of Pathology, Cerrahpasa Medical Faculty, Istanbul University) Turna, Hande (Department of Medical Oncology, Cerrahpasa Medical Faculty, Istanbul University) Kantarci, Fatih (Department of Radiology, Cerrahpasa Medical Faculty, Istanbul University) Mandel, Nil Molinas (Department of Medical Oncology, VKV American Hospital) Koca, Sedat (Department of Radiation Oncology, Faculty of Medicine Bahcesehir University)

저널정보: 아시아태평양암예방학회 Asian Pacific journal of cancer prevention : APJCP Asian Pacific journal of cancer prevention : APJCP 제15권 제4호

발행연도: 2014.1

수록면: 1,775 - 1,781 (7page)

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

Background: To assess the long term clinical outcome of preoperative radiotherapy with or without chemotherapy followed by limb sparing surgery in patients with non-metastatic soft tissue sarcomas (STS) of the extremities. Materials and Methods: Sixty patients with locally advanced STS were retrospectively analyzed. The median tumor diameter was 12 cm. All patients were treated with preoperative radiotherapy delivered with two different fractionation schedules (35Gy/10fr or 46-50Gy/23-25fr). Neoadjuvant chemotherapy was added to 44 patients with large and/or high grade tumors. Surgery was performed 2-6 weeks after radiotherapy. Chemotherapy was completed up to 6 courses after surgery in patients who had good responses. Results: Median follow-up time was 67 months (8-268 months). All of the patients had limb sparing surgery. The 5-year local control (LC), disease free (DFS) and overall survival (OSS) rates for all of the patients were 81%, 48.1% and 68.3% respectively. 5-year LC, DFS and cause specific survival (CSS) were 81.7%, 47%, 69.8%, and 80%, 60%, 60% in the chemoradiotherapy and radiotherapy groups, respectively. On univariate analysis, patients who were treated with hypofractionation experienced significantly superior LC, DFS and CSS rates with similar rates of late toxicity when compared with patients who were treated with conventional fractionation and statistical significance was retained on multivariate analysis. Conclusions: Treatment results are consistent with the literature. As neoadjuvant chemoradiotherapy provides effective LC and CSS with acceptable morbidity, it should be preferred for patients with large and borderline resectable STS.

#Soft-tissue sarcomas #preoperative radiotherapy/chemotherapy #limb-sparing surgery

참고문헌 (0)

참고문헌 신청

참고문헌이 DBpia에서 서비스 중이라면, [참고문헌 신청]을 통해 등록해보세요